Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Stromal biology of pancreatic cancer.

Chu GC, Kimmelman AC, Hezel AF, DePinho RA.

J Cell Biochem. 2007 Jul 1;101(4):887-907. Review.

PMID:
17266048
2.

Molecular aspects of stromal-parenchymal interactions in malignant neoplasms.

Zalatnai A.

Curr Mol Med. 2006 Sep;6(6):685-93. Review.

PMID:
17022738
3.

Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.

Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.

Ann Surg Oncol. 2009 Aug;16(8):2339-50. doi: 10.1245/s10434-009-0531-4. Epub 2009 May 28.

PMID:
19475450
4.

Hedgehog signaling and pancreatic tumor development.

Lauth M, Toftgård R.

Adv Cancer Res. 2011;110:1-17. doi: 10.1016/B978-0-12-386469-7.00001-3. Review.

PMID:
21704226
5.

Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.

Apte MV, Wilson JS.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:69-74. doi: 10.1111/j.1440-1746.2011.07000.x. Review.

PMID:
22320920
6.

Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas.

Fukushima N, Kikuchi Y, Nishiyama T, Kudo A, Fukayama M.

Mod Pathol. 2008 Aug;21(8):1044-53. doi: 10.1038/modpathol.2008.77. Epub 2008 May 16.

7.

Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Mahadevan D, Von Hoff DD.

Mol Cancer Ther. 2007 Apr;6(4):1186-97. Epub 2007 Apr 3. Review.

8.

Stromal biology and therapy in pancreatic cancer.

Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, Tuveson DA.

Gut. 2011 Jun;60(6):861-8. doi: 10.1136/gut.2010.226092. Epub 2010 Oct 21. Review.

PMID:
20966025
9.

The role of the tumor microenvironment in the progression of pancreatic cancer.

Farrow B, Albo D, Berger DH.

J Surg Res. 2008 Oct;149(2):319-28. doi: 10.1016/j.jss.2007.12.757. Epub 2008 Jan 10. Review.

PMID:
18639248
10.

Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.

Takehara A, Hosokawa M, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, Nakagawa H.

Cancer Res. 2007 Oct 15;67(20):9704-12.

11.

Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo.

Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi M, Lulka H, Touil I, André M, Grolleau JL, Péron JM, Chavoin JP, Bourin P, Pénicaud L, Casteilla L, Buscail L, Cordelier P.

PLoS One. 2009 Jul 17;4(7):e6278. doi: 10.1371/journal.pone.0006278.

12.

Stromal expression of SPARC in pancreatic adenocarcinoma.

Neuzillet C, Tijeras-Raballand A, Cros J, Faivre S, Hammel P, Raymond E.

Cancer Metastasis Rev. 2013 Dec;32(3-4):585-602. doi: 10.1007/s10555-013-9439-3. Review.

PMID:
23690170
13.

Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.

Damhofer H, Medema JP, Veenstra VL, Badea L, Popescu I, Roelink H, Bijlsma MF.

Mol Oncol. 2013 Dec;7(6):1031-42. doi: 10.1016/j.molonc.2013.08.004. Epub 2013 Aug 16.

14.

Molecular pathogenesis of pancreatic cancer: advances and challenges.

Welsch T, Kleeff J, Friess H.

Curr Mol Med. 2007 Aug;7(5):504-21. Review.

PMID:
17691965
15.

Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions.

Hermanova M, Trna J, Nenutil R, Dite P, Kala Z.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):732-9. doi: 10.1097/MEG.0b013e3282f945fb.

PMID:
18617777
16.
17.

Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.

Erkan M, Reiser-Erkan C, Michalski CW, Deucker S, Sauliunaite D, Streit S, Esposito I, Friess H, Kleeff J.

Neoplasia. 2009 May;11(5):497-508.

18.

Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis.

Pham NA, Schwock J, Iakovlev V, Pond G, Hedley DW, Tsao MS.

BMC Cancer. 2008 Feb 6;8:43. doi: 10.1186/1471-2407-8-43.

19.

Pancreatic cancer: a plea for good and comprehensive morphological studies.

Algül H, Schmid RM.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):713-5. doi: 10.1097/MEG.0b013e3282f9460e. Review.

PMID:
18617774
20.

Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression.

Zhou L, Zhang R, Yao W, Wang J, Qian A, Qiao M, Zhang Y, Yuan Y.

Tohoku J Exp Med. 2009 Feb;217(2):123-31.

Supplemental Content

Support Center